Prospective Assessment of CONECCT's Classification for Colorectal Lesions.
pro-CONECCT
1 other identifier
observational
750
1 country
1
Brief Summary
Colorectal neoplastic lesion endoscopic characterization is a key element for histological predictive diagnostic value in conducting best appropriate resection choice. Six classifications are necessary for fully correct characterization of different colorectal lesions. Nonetheless, it can be tricky to use so many diagnostic tools with so many subcategories in the 6 existing classifications. That's why we decided to integrate all 6 existing classification validated factors in one single chart (CONECCT chart) allowing to both predict histological diagnostic value and to propose the best appropriate resection strategy. A previous prospective and multicentre study with all French medical residents in gastroenterology was conducted in order to prove pedagogic interest of this diagnostic tool. Each student was asked to review 20 files with lesion pictures before and after lecture about CONECCT chart. This allowed us to prove that this diagnostic tool could significantly improve both histological predictive diagnostic value and therapeutic choice by French medical residents and gastroenterologists. Our hypothesis is that CONECCT's classification can improve predictive diagnostic value of colorectal lesions in over 80% of cases. Now that pedagogic interest of this diagnostic tool has been proven, we would like to carry out a larger prospective assessment in term of performance (value) of this instrument in order to both facilitate endoscopic characterization and allow a most appropriate diagnostic and therapeutic management of each colorectal lesion category.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2022
CompletedFirst Submitted
Initial submission to the registry
August 1, 2023
CompletedFirst Posted
Study publicly available on registry
August 9, 2023
CompletedAugust 9, 2023
August 1, 2023
1 year
August 1, 2023
August 1, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlation between endoscopic CONECCT's classification
assessed by one of research site operators and final histology reading of neoplastic lesion by anatomopathologist: * CONECCT 0E : neuroendocrine tumor * CONECCT IH : hyperplastic polyp * CONECCT IS : sessile serrated lesion with or without dysplasia * CONECCT IIA : low or high grade adenoma * CONECCT IIC : low or high grade adenoma or intramucosal or submucosal \<1000 micron adenocarcinoma * CONECCT III : deep invasive submucosal \> 1000 microns adenocarcinoma
Time point can be reached either 2 weeks after endoscopic resection at V1 or between 2-4 months later in case of surgery at V3
Study Arms (1)
CONECCT's classification assessment
Every patient who needs diagnostic colonoscopy because of digestive symptoms, medical or family history of colorectal cancer/polyps, positive colorectal screening test, acromegaly or referred by another gastroenterologist upon discovery of colorectal polyp after colonoscopy can join the cohort of this study and can get CONECCT's classification histological assessment of their neoplastic lesion by experienced endoscopist.
Eligibility Criteria
Every patient who needs diagnostic colonoscopy because of digestive symptoms, medical or family history of colorectal cancer/polyps, positive colorectal screening test, acromegaly or referred by another gastroenterologist upon discovery of colorectal polyp after colonoscopy can join the cohort of this study.
You may qualify if:
- both gender patients even or older than 18 years old
- patient in need of proven diagnostic or therapeutic colonoscopy for colorectal lesion resection
- patient with French Health Insurance coverage
- obtaining of oral non opposition to research after loyal, clear and complete delivery of information
You may not qualify if:
- previous attempt of lesion resection by mucosectomy
- patient with a metastatic lesion diagnosed prior to colonoscopy
- patient with no colorectal lesion
- adenomatous or sessile serrated polyposis syndrome
- patient with bowel chronic inflammatory disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Edouard Herriot
Lyon, 69437, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 1, 2023
First Posted
August 9, 2023
Study Start
July 1, 2021
Primary Completion
July 1, 2022
Study Completion
November 1, 2022
Last Updated
August 9, 2023
Record last verified: 2023-08